Targeting the gut–lung microbiota axis by means of a high-fibre diet and probiotics may have anti-inflammatory effects in COVID-19 infection
Luana Conte, Domenico Maurizio Toraldo
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 1 is a 2019 novel coronavirus, which only in the European area has led to more than 300,000 cases with at least 21,000 deaths. This manuscript aims to speculate that the manipulation of the microbial patterns through the use of probiotics and dietary fibers consumption may contribute to reduce inflammation and strengthen the immune system response in COVID-19 infection.
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)Gut floraLungSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakImmunologyInternal medicineVirologyDiseaseInfectious disease (medical specialty)OutbreakGut microbiota and healthClostridium difficile and Clostridium perfringens researchPediatric health and respiratory diseases